An economic evaluation for prevention of diabetes mellitus in a developing country: a modelling study - PubMed (original) (raw)
An economic evaluation for prevention of diabetes mellitus in a developing country: a modelling study
Xiaoqian Liu et al. BMC Public Health. 2013.
Abstract
Background: The serious consequences of diabetes mellitus, and the subsequent economic burden, call for urgent preventative action in developing countries. This study explores the clinical and economic outcomes of strategies that could potentially prevent diabetes based on Chinese circumstances. It aims to provide indicators for the long-term allocation of healthcare resources for authorities in developing countries.
Methods: A representative sample of Chinese adults was used to create a simulated population of 20,000 people aged 25 years and above. The hybrid decision tree Markov model was developed to compare the long-term clinical and economic outcomes of four simulated diabetes prevention strategies with a control group, where no prevention applied. These preventive strategies were the following: (i) one-off screening for undiagnosed diabetes and impaired glucose tolerance (IGT), with lifestyle interventions on diet, (ii) on exercise, (iii) on diet combined exercise (duo-intervention) respectively in those with IGT, and (iv) one-off screening alone. Independent age-specific models were simulated based on diverse incidences of diabetes, mortalities and health utilities. The reported outcomes were the following: the remaining survival years, the quality-adjusted life years (QALYs) per diabetes or IGT subjects, societal costs per simulated subject and the comparisons between preventions and control over 40 years. Sensitivity analyses were performed based on variations of all assumptions, in addition to the performance and the compliance of screening.
Results: Compared with the control group, all simulated screening programmes prolonged life expectancy at the initiation ages of 25 and 40 years, postponed the onset of diabetes and increased QALYs at every initiation age. Along with an assumption of six years intervention, prevention programmes were associated with cost-saving compared with the control group, especially in the population aged 25 years. The savings were at least US$2017 per subject, but no statistically significant difference was observed among the intervention strategies within each age groups. The cost savings were reduced when screening was affected by poor performance and noncompliance.
Conclusions: Developing countries have few effective strategies to manage the prevention of diabetes. One-off screening for undiagnosed diabetes and IGT, with appropriate lifestyle interventions for those with IGT are cost saving in China, especially in young adults.
Figures
Figure 1
Progression of individuals screened and intervened for diabetes. The hybrid tree combined a decision tree and Markov models. The decision tree (the left side) consisted of five main arms representing five scenarios. The first three scenarios involved screening for undiagnosed diabetes and IGT followed by any of the three active lifestyle interventions (diet, exercise, and duo-intervention), which were applied to the IGT subjects. The fourth scenario involved screening for undiagnosed diabetes and IGT, but without formal interventions, and the fifth scenario involved control group. Nine Markov models represented the nature history of diabetes (the lower right side). Each of them consisted of eight states: IGT, normal glucose tolerance, onset of diabetes, four diabetes complication states and death. The IGT states were tunnel states that included six temporary ones representing 6 years lifestyle interventions. Transition probability, costs, benefits were required for each state. Three separate models were performed for strategies starting at age of 25, 40 and 60 respectively. “2-hour PG” means 2-hour plasma glucose after breakfast. “DM” means diabetes mellitus. “OGTT” means oral glucose tolerance test. “IGT” means impaired glucose tolerance. “NORMAL GT” represented normal glucose tolerance state. “DIABETES COMPLICATIONS” included four different diabetes complications states: cardiovascular disease, retinopathy, nephropathy, and overt neuropathy disease. We numbered the transition paths corresponding to the main transition parameters in Table 1. (#The complement probabilities of one branch. *The life-table information used to model competing causes of death. @The proportion of individuals with normal PG. ¢, £, ¤ Transition parameters which determined whether a subject would receive interventions. §, ¶, ß, ð,&: Transition parameters applied to the Markov models: ð1 to ð4 determined transitions from onset of diabetes state to complications states respectively; &1 and &2 determined transitions from CVD or nephropathy to death state. We did not include the neuropathy-specific and retinopathy-specific mortalities, since these complications are not fatal).
Similar articles
- Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom.
Palmer AJ, Roze S, Valentine WJ, Spinas GA, Shaw JE, Zimmet PZ. Palmer AJ, et al. Clin Ther. 2004 Feb;26(2):304-21. doi: 10.1016/s0149-2918(04)90029-x. Clin Ther. 2004. PMID: 15038953 - The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.
Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE; Diabetes Prevention Program Research Group. Herman WH, et al. Ann Intern Med. 2005 Mar 1;142(5):323-32. doi: 10.7326/0003-4819-142-5-200503010-00007. Ann Intern Med. 2005. PMID: 15738451 Free PMC article. - Screening for type 2 diabetes: literature review and economic modelling.
Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, Williams R, John A. Waugh N, et al. Health Technol Assess. 2007 May;11(17):iii-iv, ix-xi, 1-125. doi: 10.3310/hta11170. Health Technol Assess. 2007. PMID: 17462167 Review. - Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.
Eddy DM, Schlessinger L, Kahn R. Eddy DM, et al. Ann Intern Med. 2005 Aug 16;143(4):251-64. doi: 10.7326/0003-4819-143-4-200508160-00006. Ann Intern Med. 2005. PMID: 16103469
Cited by
- Impact of Attendance to a Pharmacist-Managed Medication Adherence Clinic on Glycemic Control and Risk Factors for Non-Completion Among Persons with Type 2 Diabetes Mellitus in Selangor, Malaysia.
Hassan F, Hatah E, Chong WW, Ali AM. Hassan F, et al. Ther Clin Risk Manag. 2024 Aug 12;20:495-503. doi: 10.2147/TCRM.S442026. eCollection 2024. Ther Clin Risk Manag. 2024. PMID: 39156759 Free PMC article. - The intervention strategies and service model for pharmacist-led diabetes management: a scoping review.
Hassan F, Hatah E, Ali AM, Wen CW. Hassan F, et al. BMC Health Serv Res. 2023 Jan 18;23(1):46. doi: 10.1186/s12913-022-08977-1. BMC Health Serv Res. 2023. PMID: 36653832 Free PMC article. Review. - Cost-effectiveness of two screening strategies based on Chinese diabetes risk score for pre-diabetes in China.
Hao J, Yao Q, Lin Y, Sun Y, Zhang B, Hu M, Zhang J, Zhao N, Pei J, Liu Z, Zhu C. Hao J, et al. Front Public Health. 2022 Nov 30;10:1018084. doi: 10.3389/fpubh.2022.1018084. eCollection 2022. Front Public Health. 2022. PMID: 36530668 Free PMC article. - System Dynamic Model Simulates the Growth Trend of Diabetes Mellitus in Chinese Population: Implications for Future Urban Public Health Governance.
Li H, Chang GY, Jiang YH, Xu L, Shen L, Gu ZC, Lin HW, Shi FH. Li H, et al. Int J Public Health. 2022 Nov 11;67:1605064. doi: 10.3389/ijph.2022.1605064. eCollection 2022. Int J Public Health. 2022. PMID: 36439277 Free PMC article. - Application of decision analytical models to diabetes in low- and middle-income countries: a systematic review.
Twumwaa TE, Justice N, Robert VM, Itamar M. Twumwaa TE, et al. BMC Health Serv Res. 2022 Nov 23;22(1):1397. doi: 10.1186/s12913-022-08820-7. BMC Health Serv Res. 2022. PMID: 36419101 Free PMC article.
References
- Weber BM, Narayan K. Diabetes prevention should be a public-health priority. Lancet. 2008;371:473–474. - PubMed
- Wen-ying Y. Achieve great success, and blaze a trail: review of clinical and basic research progress of Chinese diabetes in the 21st century. Chin Med J. 2009;122:2525–2529. - PubMed
- Wang W, McGreevey WP, Chaowei F, Zhan S, Luan R, Chen W, Biao X. Type 2 diabetes mellitus in China: a preventable economic burden. AJMC. 2009;15:593–601. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous